Multicancer Blood Test, PET-CT Combo Feasible for Cancer Screen
One percent of participants underwent PET-CT imaging due to false-positive blood tests.
Diagnosis & Disease Information
Aromatherapy With Peppermint Essential Oil May Help Alleviate Nausea Associated With Chemotherapy
A randomized study determined the efficacy of adding peppermint essential oil to a cool wash cloth to ease nausea associated with chemotherapy.
Whole-Body DW MRI Can Help Assess Pediatric Tumor Response
Good agreement for treatment response assessments with DW MRI, FDG PET seen in children, young adults.
Evaluation of Primary Cardiac Lymphoma Incidence and Prognosis Using SEER Database
SEER analysis reveals age, Ann Arbor stage, and chemotherapy as critical factors affecting prognosis in patients with primary cardiac lymphoma.
Health Insurance Coverage Disruption Impedes Cancer Care
Findings consistent across cancer continuum, from screening to treatment and end-of-life care.
Fewer Children Enrolling in Pediatric Cancer Trials
Adolescent and young adult cancer patients underrepresented in clinical trials.
Impact of COVID-19 on Oncology Clinical Trials Discussed
Recommendations for sustaining cancer care access include permanent expanded support for telehealth.
The International Society of Nurses in Cancer Care Releases Its COVID-19 Position Statement
Inclusion of nurses in the development of health care programs relating to prevention and management of COVID-19 infection was a key element of the ISNCC position statement.
Patients With Cancer Seem More Vulnerable to COVID-19
Frequency of severe events highest for patients with hematologic cancer, lung cancer, and metastatic cancer.
New Dosing Schedule Approved for All Keytruda Indications
The FDA has approved the supplemental Biologics License Application (sBLA) for Keytruda® (Merck) to include an additional recommended dosage of 400mg every 6 weeks across all adult indications.
- Loading...
Loading...
Next post in General Hematology
Loading... 
Loading...